Clinical Trial Update: Clinical Trial With MBK-01, Intestinal Microbiota Capsules, for the Treatment of Patients With Recurrent Diverticulitis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial (NCT06687382) is testing MBK-01, an intestinal microbiota capsule, for recurrent diverticulitis and diverticulitis of the sigmoid colon…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diverticulitis
• Diverticulitis of Sigmoid Colon

Drugs mentioned

• MBK-01

Snippet

Sponsor: Mikrobiomik Healthcare Company S.L. | Conditions: Diverticulitis, Diverticulitis of Sigmoid | Phase 2 | Status: RECRUITING